Multidomain cognitive training for brain and cardiovascular health in hypertension with mild cognitive impairment (DELIGHT): a multicentre, double-blind, randomised, active-controlled, clinical trial

Background Hypertension and cognitive decline interact bidirectionally through the brain-heart axis. This study evaluated the multidomain adaptive computerised cognitive training (CCT) as a digital therapeutic for improving cognition and inducing neural and haemodynamic changes in hypertensive patients with mild cognitive impairment (MCI). Methods This multicentre, double-blind, randomised, active-controlled, clinical trial was conducted at 11 hospitals across six Chinese regions. Eligible participants were adults aged 60 years or older with hypertension, subjective cognitive decline, and a Montreal Cognitive Assessment (MoCA) score of less than 26. Patients were randomly assigned (in blocks of 6) 1:1 to receive 12 weeks of multidomain adaptive CCT (MD-CCT) or fixed-domain CCT (FD-CCT). At 12-week follow-up, participants assigned to MD-CCT were randomly assigned 1:1 to continue or stop training for another 12 weeks. The primary outcome was global cognitive improvement at 12 weeks. Secondary outcomes included subdomain and psychological changes at 12 and 24 weeks. Exploratory outcomes included neuroimaging measures derived from functional and structural ultra-high-field 7-T MRI, as well as haemodynamic indices of systolic blood pressure, diastolic blood pressure, heart rate, and rate-pressure product. This trial is registered at ClinicalTrials.gov, NCT05704270, and is complete. Findings Between March 8 and Oct 13, 2023, 217 participants were enrolled (MD-CCT n=108; FD-CCT n=109). At week 12, no significant between-group difference emerged in multidomain cognitive improvement (13% [13 of 101] vs 17% [17 of 103]; adjusted odds ratio 0·59, 95% CI 0·25–1·36; p=0·21). Both groups showed within-group gains in MoCA and working memory (p FDR s <0·026), although only the MD-CCT group had improved processing speed (p FDR = 0·041). The MD-CCT group showed enhanced functional connectivity in attention, executive control, and episodic memory networks (p FDR s <0·043), and increased grey matter density in hippocampus (p FDR = 0·040), along with greater reduction in diastolic blood pressure, heart rate and rate-pressure product (p FDR s <0·022) relative to FD-CCT. Alterations in functional connectivity mediated the intervention effect on general cognition (indirect effects ranging from 0·71 to 1·17; p FDR s <0·038) and were also negatively associated with reductions in heart rate (p FDR s <0·045). At 24-week follow-up, no significant difference in multidomain cognitive improvement proportion emerged between the MD-keep and MD-stop groups (10% [5 of 48] vs 19% [10 of 53], p FDR = 0·675). Both subgroups showed greater diastolic blood pressure reduction than the FD-CCT group (p FDR s <0·017). Interpretation The MD-CCT did not differ significantly from FD-CCT in cognitive improvement, but uniquely benefited neural and haemodynamic outcomes, supporting its potential as an integrated digital therapeutic for hypertension with cognitive impairment. Funding Ministry of Science and Technology of the People's Republic of China, the Capital's Fund for Health Improvement and Research, and the Beijing Municipal Science & Technology Commission, Administrative Commission of Zhongguancun Science Park.

Authors

Institutions

Publication Details

Journal
EClinicalMedicine
Published
2026-11-18
DOI
https://doi.org/10.1016/j.eclinm.2026.104308
Primary Topic
Dementia and Cognitive Impairment Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Multidomain cognitive training for brain and cardiovascular health in hypertension with mild cognitive impairment (DELIGHT): a multicentre, double-blind, randomised, active-controlled, clinical trial

Jianjun Mu, Wei Zhao, Longjun Cai, Yi‐Bang Cheng et al.
2 links
EClinicalMedicine
Dementia and Cognitive Impairment Research
article

Multidomain cognitive training for brain and cardiovascular health in hypertension with mild cognitive impairment (DELIGHT): a multicentre, double-blind, randomised, active-controlled, clinical trial

Jianjun Mu, Wei Zhao, Longjun Cai, Yi‐Bang Cheng, Shijun Xia, Yu Kong, Yi Chen, Qianhui Guo, Yuewen Sun, Danyang Wang, Jianzeng Dong, Meiqi Zhao, Changyuan Liu, Hongmei Guo, Xiaoping Chen, Xiaoxia Liu, Tingyan Xu, Ling Han, Yan Lu, Ji-Guang Wang, Changsheng Ma
article en

Abstract

Background Hypertension and cognitive decline interact bidirectionally through the brain-heart axis. This study evaluated the multidomain adaptive computerised cognitive training (CCT) as a digital therapeutic for improving cognition and inducing neural and haemodynamic changes in hypertensive patients with mild cognitive impairment (MCI). Methods This multicentre, double-blind, randomised, active-controlled, clinical trial was conducted at 11 hospitals across six Chinese regions. Eligible participants were adults aged 60 years or older with hypertension, subjective cognitive decline, and a Montreal Cognitive Assessment (MoCA) score of less than 26. Patients were randomly assigned (in blocks of 6) 1:1 to receive 12 weeks of multidomain adaptive CCT (MD-CCT) or fixed-domain CCT (FD-CCT). At 12-week follow-up, participants assigned to MD-CCT were randomly assigned 1:1 to continue or stop training for another 12 weeks. The primary outcome was global cognitive improvement at 12 weeks. Secondary outcomes included subdomain and psychological changes at 12 and 24 weeks. Exploratory outcomes included neuroimaging measures derived from functional and structural ultra-high-field 7-T MRI, as well as haemodynamic indices of systolic blood pressure, diastolic blood pressure, heart rate, and rate-pressure product. This trial is registered at ClinicalTrials.gov, NCT05704270, and is complete. Findings Between March 8 and Oct 13, 2023, 217 participants were enrolled (MD-CCT n=108; FD-CCT n=109). At week 12, no significant between-group difference emerged in multidomain cognitive improvement (13% [13 of 101] vs 17% [17 of 103]; adjusted odds ratio 0·59, 95% CI 0·25–1·36; p=0·21). Both groups showed within-group gains in MoCA and working memory (p FDR s <0·026), although only the MD-CCT group had improved processing speed (p FDR = 0·041). The MD-CCT group showed enhanced functional connectivity in attention, executive control, and episodic memory networks (p FDR s <0·043), and increased grey matter density in hippocampus (p FDR = 0·040), along with greater reduction in diastolic blood pressure, heart rate and rate-pressure product (p FDR s <0·022) relative to FD-CCT. Alterations in functional connectivity mediated the intervention effect on general cognition (indirect effects ranging from 0·71 to 1·17; p FDR s <0·038) and were also negatively associated with reductions in heart rate (p FDR s <0·045). At 24-week follow-up, no significant difference in multidomain cognitive improvement proportion emerged between the MD-keep and MD-stop groups (10% [5 of 48] vs 19% [10 of 53], p FDR = 0·675). Both subgroups showed greater diastolic blood pressure reduction than the FD-CCT group (p FDR s <0·017). Interpretation The MD-CCT did not differ significantly from FD-CCT in cognitive improvement, but uniquely benefited neural and haemodynamic outcomes, supporting its potential as an integrated digital therapeutic for hypertension with cognitive impairment. Funding Ministry of Science and Technology of the People's Republic of China, the Capital's Fund for Health Improvement and Research, and the Beijing Municipal Science & Technology Commission, Administrative Commission of Zhongguancun Science Park.

EClinicalMedicineVol. 102
Shanghai Jiao Tong University (CN), Capital Medical University (CN), Dalian Medical University (CN), Sichuan University (CN), Ruijin Hospital (CN), West China Hospital of Sichuan University (CN), Beijing Anzhen Hospital (CN), First Affiliated Hospital of Xi'an Jiaotong University (CN), First Hospital of Jilin University (CN), Shanghai Institute of Hypertension (CN), First Affiliated Hospital of Dalian Medical University (CN), Peking University Third Hospital (CN), First Bethune Hospital of Jilin University (CN), Jiangsu Province Hospital (CN), State Key Laboratory of Medical Genomics (CN)
Ministry of Science and Technology of the People's Republic of China, Beijing Municipal Health Commission, Beijing Municipal Science and Technology Commission
Good health and well-being
Dementia and Cognitive Impairment Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon